Framework

How governance, knowledge, risk, change, performance monitoring and continual improvement connect across the product lifecycle.

2 min

ICH Q10 describes the pharmaceutical quality system (PQS) across development, technology transfer, commercial manufacturing and discontinuation. Knowledge management and quality risk management support decisions across all four stages.

01

Assign ownership and review performance

Senior management sets policy, resources the quality function and reviews whether the system meets its objectives. Assign accountable owners and escalate unresolved risks that cross site or functional boundaries.

  • Evidence: Management-review minutes with decisions, owners and due dates.
02

Monitor processes and product quality

Use critical quality attributes, process trends, complaints, stability, deviations and batch-review data to detect drift. Review data by product, site and equipment where aggregation could hide a cluster.

  • Evidence: Approved trend rules, investigation triggers and product quality reviews.
03

Investigate and improve

Connect significant quality signals to proportionate investigations and CAPA. Check that actions reduce the targeted failure mode under routine conditions and route unresolved risks back to management.

  • Evidence: Root-cause rationale, effectiveness criteria and trend review.
04

Control lifecycle changes

Assess effects on validated state, process controls, suppliers, stability and approved dossiers before implementing a change. Define any regulatory filing dependencies and verify the intended outcome after implementation.

  • Evidence: Cross-functional change assessment, approvals and post-implementation verification.
05

Maintain product knowledge

Transfer assumptions, development results and process limitations with the approved manufacturing instructions. At discontinuation, assign ownership for ongoing stability, complaints, retained records and obligations that continue after supply ends.

  • Evidence: Transfer package and documented discontinuation handover.